Literature DB >> 31049251

Clinical Efficacy of Tinnitus Retraining Therapy Based on Tinnitus Questionnaire Score and Visual Analogue Scale Score in Patients with Subjective Tinnitus.

Sanjana Vijay Nemade1, Kiran Jaywant Shinde1.   

Abstract

OBJECTIVE: Tinnitus is the annoying sensation of sound perception without acoustic stimulus. Tinnitus retraining therapy (TRT) is the habituation therapy used for the management of chronic subjective tinnitus. The objective of the study is to describe TRT and to evaluate its efficacy in patients with subjective tinnitus.
METHODS: In total, 58 patients with tinnitus who did not respond to medications were enrolled in the TRT program. TRT included counseling as described in the neurophysiological model of tinnitus and sound therapy (aided or unaided) for six months. The tinnitus severity grade (TSG) 1-5, based on a validated tinnitus questionnaire score (TQS), and the visual analogue scale (VAS) score were documented before and after therapy.
RESULTS: Before TRT, 53 patients (91.3%) exhibited TSG 3-5, and the average VAS score was 6.7±2.1. After TRT for two months, 49 patients (84.4%) showed TSG 1-3, and the average VAS score was 3.2±2.4. After six months of TRT, most of the patients found remarkable improvement in the symptoms, and 51 patients (87.9%) exhibited TSG 1-2, and the average VAS score was 2.1±2.6. Statistically significant difference was found in TSG and VAS score before and after TRT. Statistically significant correlation was observed between TSG and VAS score.
CONCLUSION: TRT is an useful approach for amelioration of tinnitus. TQS is a very effective, cheap, and easy method to help otologists to grade the patients as per the severity of symptoms.

Entities:  

Keywords:  Tinnitus; tinnitus retraining therapy; treatment outcome; visual analogue scale

Year:  2019        PMID: 31049251      PMCID: PMC6461338          DOI: 10.5152/tao.2019.3091

Source DB:  PubMed          Journal:  Turk Arch Otorhinolaryngol        ISSN: 2667-7466


  6 in total

1.  Clinical prognostic factors for tinnitus retraining therapy with a sound generator in tinnitus patients.

Authors:  Yosuke Ariizumi; Akio Hatanaka; Ken Kitamura
Journal:  J Med Dent Sci       Date:  2010-03

2.  Open ear hearing aids in tinnitus therapy: An efficacy comparison with sound generators.

Authors:  Marta Parazzini; Luca Del Bo; Margaret Jastreboff; Gabriella Tognola; Paolo Ravazzani
Journal:  Int J Audiol       Date:  2011-05-19       Impact factor: 2.117

Review 3.  Clinical efficacy of tinnitus retraining therapy and cognitive behavioural therapy in the treatment of subjective tinnitus: a systematic review.

Authors:  R Grewal; P M Spielmann; S E M Jones; S S M Hussain
Journal:  J Laryngol Otol       Date:  2014-11-24       Impact factor: 1.469

Review 4.  Tinnitus retraining therapy: a different view on tinnitus.

Authors:  Pawel J Jastreboff; Margaret M Jastreboff
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2006-03-03       Impact factor: 1.538

5.  Comparison of tinnitus masking and tinnitus retraining therapy.

Authors:  James A Henry; Martin A Schechter; Stephen M Nagler; Stephen A Fausti
Journal:  J Am Acad Audiol       Date:  2002 Nov-Dec       Impact factor: 1.664

6.  The effect of tinnitus retraining therapy on chronic tinnitus: A controlled trial.

Authors:  Carol A Bauer; Jennifer L Berry; Thomas J Brozoski
Journal:  Laryngoscope Investig Otolaryngol       Date:  2017-05-28
  6 in total
  3 in total

Review 1.  The Pathological Mechanisms and Treatments of Tinnitus.

Authors:  Sana Saeed; Qudsia Umaira Khan
Journal:  Discoveries (Craiova)       Date:  2021-09-30

2.  Management Strategies and Imaging Observation of Early and Delayed Intelligent Treatment of Meniscus Sports Injury under Knee Osteoarthroscopy.

Authors:  Tong Deng; Xu Li; Zhe Guo; Shuang Guo; Yan Zhou; Wei Zhang; Ying Zhang
Journal:  Scanning       Date:  2022-08-30       Impact factor: 1.750

3.  A data-driven approach to clinical decision support in tinnitus retraining therapy.

Authors:  Katarzyna A Tarnowska; Zbigniew W Ras; Pawel J Jastreboff
Journal:  Front Neuroinform       Date:  2022-09-28       Impact factor: 3.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.